New Mismatch Repair Test Identifies Patients for Pembrolizumab ...Middle East

Medscape - News
The Ventana panel for DNA mismatch repair (MMR) is now approved to identify patients suitable for treatment with pembrolizumab (Keytruda). FDA Approvals

Hence then, the article about new mismatch repair test identifies patients for pembrolizumab was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Mismatch Repair Test Identifies Patients for Pembrolizumab )

Apple Storegoogle play

Last updated :

Also on site :